Disclosed herein are compositions and methods for treating subjects with conditions related to Inositol 1,4,5-trisphosphate receptor (InsP3R). Described herein are mutants of InsP3R, methods of making mutants, and methods of using InsP3R mutants for the treatment of a disease or condition.